Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
11.41
-0.18 (-1.55%)
Nov 20, 2024, 4:00 PM EST - Market closed
Bioventus Employees
Bioventus had 970 employees as of December 31, 2023. The number of employees decreased by 150 or -13.39% compared to the previous year.
Employees
970
Change (1Y)
-150
Growth (1Y)
-13.39%
Revenue / Employee
$572,228
Profits / Employee
-$40,703
Market Cap
745.85M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 970 | -150 | -13.39% |
Dec 31, 2022 | 1,120 | -80 | -6.67% |
Dec 31, 2021 | 1,200 | 500 | 71.43% |
Dec 31, 2020 | 700 | 50 | 7.69% |
Dec 31, 2015 | 650 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Avanos Medical | 3,771 |
Embecta | 2,200 |
Pacira BioSciences | 712 |
Cronos Group | 356 |
Prothena Corporation | 173 |
CARGO Therapeutics | 116 |
Cullinan Therapeutics | 85 |
BVS News
- 15 days ago - Bioventus Inc. (BVS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Bioventus Reports Third Quarter Financial Results - GlobeNewsWire
- 23 days ago - Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 - GlobeNewsWire
- 3 months ago - Executives Buying W. P. Carey And 2 Other Stocks - Benzinga
- 3 months ago - Healing Numbers, Hurting Valuation: Bioventus' Mixed Bag In Q2 2024 - Seeking Alpha
- 3 months ago - Bioventus Inc. (BVS) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference - GlobeNewsWire
- 3 months ago - Bioventus Reports Second Quarter Financial Results - GlobeNewsWire